Generic Medicine

Shop Seroflo 50mcg/250mcg Multihaler Online

Pack Size/Qty Price Unit Price  
3 Inhaler/s $135.00 $45.00

OUT OF STOCK

2 Inhaler/S $94.00 $47.00

OUT OF STOCK

1 Inhaler $48.00 $48.00

OUT OF STOCK

Generic Name : Salmeterol and Fluticasone Propionate

Brand Name : Advair Multi Haler

Manufacturer Name : Cipla Ltd - Pharmaceutical Company

Product Code : CRX 260

Delivery Days : 10 to 15 working days

Packaging : Multihaler

Prescribed For : Asthma (Wheezing & Shortness of Breathing)

Descriptions

Seroflo 50mcg/250mcg Multihaler 30Md

Seroflo 50mcg/250mcg Multihaler 30Mdi is a pharmaceutical inhalation product that combines two active ingredients, fluticasone propionate and salmeterol xinafoate, to provide effective and comprehensive management of respiratory conditions, particularly asthma and chronic obstructive pulmonary disease (COPD). This inhaler is a vital component in the treatment arsenal for individuals dealing with these chronic respiratory conditions, offering a convenient and targeted approach to controlling symptoms and improving overall lung function.

The primary active ingredients in Seroflo 50mcg/250mcg Multihaler are fluticasone propionate and salmeterol xinafoate. Fluticasone propionate is a corticosteroid that works by reducing inflammation in the airways, while salmeterol xinafoate is a long-acting beta2-agonist that helps to relax and open the airways, facilitating easier breathing. The combination of these two drugs provides a synergistic effect, addressing both the inflammatory component and bronchoconstriction associated with conditions like asthma and COPD.

One of the key strengths of Seroflo 50mcg/250mcg Multihaler is its delivery system. The Multihaler device is a user-friendly and efficient inhalation device designed to ensure accurate dosing and ease of use. The inhaler is equipped with a built-in dose counter, allowing patients to keep track of the remaining doses and ensuring that they are aware when the inhaler needs to be replaced. This feature promotes adherence to the prescribed treatment regimen and enhances patient compliance, both critical factors in managing chronic respiratory conditions effectively.

The 50mcg/250mcg strength of Seroflo indicates the specific dosage of fluticasone propionate (50mcg) and salmeterol xinafoate (250mcg) in each inhalation. This balanced combination is tailored to meet the needs of patients requiring moderate-level control of their respiratory symptoms. The inclusion of two active ingredients with complementary mechanisms of action addresses both the inflammatory and bronchodilator aspects of respiratory diseases, providing a comprehensive and holistic approach to treatment.

Fluticasone propionate, being a corticosteroid, exerts its anti-inflammatory effects by inhibiting the production of various inflammatory mediators and reducing the activity of inflammatory cells in the airways. This helps to prevent and control inflammation, leading to a reduction in symptoms such as wheezing, shortness of breath, and cough in individuals with asthma or COPD.

Salmeterol xinafoate, on the other hand, acts as a long-acting beta2-agonist, promoting bronchodilation by relaxing the smooth muscles in the airways. This results in the widening of the air passages, making it easier for individuals to breathe. The extended duration of action of salmeterol xinafoate allows for twice-daily dosing, contributing to sustained bronchodilation throughout the day and night.

The use of Seroflo 50mcg/250mcg Multihaler is typically guided by a healthcare professional who assesses the individual patient's condition and prescribes the appropriate strength and dosing regimen. It is crucial for patients to follow the prescribed instructions for use, ensuring they receive the maximum benefit from the medication while minimizing the risk of potential side effects.

Like any medication, Seroflo 50mcg/250mcg Multihaler may be associated with certain side effects, and individuals should be aware of these potential reactions. Common side effects may include throat irritation, hoarseness, cough, and fungal infections in the mouth. Serious side effects are rare but can include paradoxical bronchospasm (a sudden and severe narrowing of the airways) and increased blood pressure.

In conclusion, Seroflo 50mcg/250mcg Multihaler 30Mdi stands as a crucial therapeutic option for individuals grappling with asthma and COPD. Its combination of fluticasone propionate and salmeterol xinafoate addresses both the inflammatory and bronchodilator aspects of these conditions, providing a comprehensive and targeted approach to symptom management. The user-friendly Multihaler device enhances patient compliance, and the built-in dose counter aids in keeping track of medication usage. With the right guidance from healthcare professionals, Seroflo 50mcg/250mcg Multihaler plays a vital role in improving the quality of life for those affected by chronic respiratory diseases.

 

Uses

No details found!

Side Effect

No details found!

Interaction

No details found!

Warnings

No details found!

Faq

No details found!

Review

No Review Found!

Post Your Comments